S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,102.91 +0.32%
Next Bullish Trade
Sign in
AVTR

Avantor, Inc. NYQ · AVTR

$11.07 -0.19 (-1.69%)
Extended · +1.65σ Grade C
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · AVTR

Momentum reads · latest daily bar
Last
$11.07
-0.19 (-1.69%)
Mkt cap
$7.6B
Healthcare
RSI(14)
64.7
neutral
Stochastic %K
83.2
overbought
MFI(14)
68.9
neutral
ADX(14)
38.5
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $1.6B $0.0B $0.1B $0.0B 2.7% 6.3%
2025-12-31 $1.7B $0.1B $0.1B $0.1B 3.1% 7.9%
2025-09-30 $1.6B $-0.7B $0.1B $0.2B -43.8% 8.4%
2025-06-30 $1.7B $0.1B $0.1B $0.1B 3.8% 7.7%
2025-03-31 $1.6B $0.1B $0.1B $0.1B 4.1% 9.3%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare AVTR vs peers

Line AVTR up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing AVTR META×
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP
Verdict
Weighted score 0-100 across 2 tickers · best in green
#1
AVTR
score 50.0
3/5 inputs
Sentiment scores perfect 100 dominating weighted rank despite zero quality data and extended technical zone at 1.65 sigma.
quality 0momentum 50sentiment 100
#2
META
score 48.8
5/5 inputs
Balanced across all categories with 50-58 scores but sentiment weakness at 33 drags overall weighted performance below AVTR.
value 50growth 50quality 58momentum 50sentiment 33
AVTR
AVTR
$11.07
-1.69%
Snapshot
Price 11.07
Day % -1.69
1M % 15.67
3M % 34.02
YTD % -3.4
Market cap —
ADV ($) —
Beta —
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 7.17
Dist ATR (σ) 1.65
OdysseyHQ grade C
Confluence 4
Valuation
P/E (ttm) —
P/E (fwd) —
P/S —
EV/EBITDA —
P/B —
FCF yield —
PEG —
Growth
Revenue yoy —
EPS yoy —
FCF yoy —
Revenue trend 8Q
Quality
Gross margin —
Operating margin —
Net margin —
ROE —
ROA —
Debt / Equity —
Interest cov. -1.6
Technicals
RSI(14) 64.7
MACD signal bull
vs 50-DMA 18.58
vs 200-DMA 7.43
vs 52w high -30.51
HV-30 48.8
Sentiment
Analyst rec —
Target upside —
Insider buy-sell 90d 12
Risk
Short interest —
Days to cover —
Next earnings —
Full AVTR dashboard →
META
Meta Platforms, Inc.
$646.01
-2.79%
Snapshot
Price 646.01
Day % -2.79
1M % 7.63
3M % -4.56
YTD % -0.68
Market cap 1639846903808.0
ADV ($) 11732836381.40332
Beta 1.246
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 3.85
Dist ATR (σ) 0.91
OdysseyHQ grade C
Confluence 5
Valuation
P/E (ttm) 23.474201
P/E (fwd) 17.782232
P/S 7.628508
EV/EBITDA 15.053
P/B 6.7283597
FCF yield 0.0156
PEG 0.94
Growth
Revenue yoy 0.331
EPS yoy 0.624
FCF yoy —
Revenue trend 8Q
Quality
Gross margin 0.81941
Operating margin 0.40617
Net margin 0.32837
ROE 0.32930002
ROA 0.16395001
Debt / Equity 0.36
Interest cov. 74.76
Technicals
RSI(14) 56.8
MACD signal bull
vs 50-DMA 6.86
vs 200-DMA 0.86
vs 52w high -18.87
HV-30 52.2
Sentiment
Analyst rec 1.34921
Target upside 27.35
Insider buy-sell 90d -28
Risk
Short interest 1.5700001000000001
Days to cover 1.82
Next earnings 2026-07-29
Full META dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-29 0.17 0.16 +8.2% +3.2%
2026-02-11 0.22 0.22 +1.5% -5.2%
2025-10-29 0.22 0.23 -2.3% -4.6%
2025-08-01 0.24 0.25 -2.9% -0.5%
2025-04-25 0.23 0.23 -0.7% -3.4%
2025-02-07 0.27 0.26 +4.5% -0.8%
2024-10-25 0.26 0.25 +2.1% +0.9%
2024-07-26 0.25 0.23 +7.7% +2.5%
2024-04-26 0.22 0.20 +9.6% +0.6%
2024-02-14 0.25 0.22 +12.1% -1.4%
2023-10-27 0.25 0.25 -0.3% -3.8%
2023-07-28 0.28 0.29 -4.4% -3.3%
2023-04-28 0.29 0.29 +1.6% +3.9%
2023-02-03 0.32 0.30 +6.0% +1.6%
2022-10-28 0.34 0.33 +3.0% +4.9%
2022-07-28 0.37 0.38 -1.5% -10.2%
2022-04-28 0.38 0.36 +7.0% +7.0%
2022-02-03 0.36 0.33 +7.8% -1.7%
2021-10-28 0.35 0.32 +9.6% +5.4%
2021-07-29 0.35 0.31 +13.5% +0.9%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
AVTR ★ $8B — 13.0 1.2 11.7 1.3 32.1% 0.0% -33.3% 6.47%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0% —
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% — 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 54.73%

HolderShares% out
Dodge & Cox Inc. 119,648,329 17.52%
Blackrock Inc. 65,703,554 9.62%
Vanguard Portfolio Management LLC 31,275,847 4.58%
Vanguard Capital Management LLC 30,606,112 4.48%
Wellington Management Group, LLP 24,224,156 3.55%
Greenhaven Associates, Inc. 22,593,838 3.31%
Barrow, Hanley Mewhinney & Strauss, 22,358,399 3.27%
State Street Corporation 20,721,079 3.03%
Engine Capital Management, LP 19,780,830 2.90%
Dimensional Fund Advisors LP 16,894,649 2.47%

Insider activity · 90d

12 buys / 0 sells · ratio 12.0 · Finnhub

  • Walker Corey F 384,535 @ $9.58
  • LUCIER GREGORY T BUY 60,000 @ $8.32
  • Murthy Mala BUY 69,479
  • Dingemans Simon BUY 31,495
  • Makin Louise BUY 47,140
  • SEVERINO MICHAEL BUY 85,821
  • Massaro Joseph R BUY 77,408
  • LUCIER GREGORY T BUY 34,006
  • SUMME GREGORY L BUY 83,381
  • MEHRA SANJEEV K BUY 33,376

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$7.0
Mean
$10.4375
High
$19.0
Analysts
16
Recommendation distribution · period 2026-07-01
1
2
16
2
4
Revision trend (2026-04-01 → 2026-07-01): net -3 → -3 0 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-17 8-K view ·
4 2026-06-22 FORM 4 view ·
8-K 2026-05-12 8-K view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-11 FORM 4 view ·
4 2026-05-05 FORM 4 view ·
4 2026-05-05 FORM 4 view ·
10-Q 2026-04-29 10-Q view ·
8-K 2026-04-29 8-K view ·
8-K 2026-04-23 8-K view ·
4 2026-04-06 FORM 4 view ·
8-K 2026-04-01 8-K view ·
DEF 14A 2026-03-27 DEFINITIVE PROXY STATEMENT view ·
4 2026-03-11 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-25 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-12 FORM 4 view ·
8-K 2026-02-11 8-K view ·
10-K 2026-02-11 10-K view ·
4 2026-01-12 FORM 4 view ·
8-K 2025-12-18 8-K view ·
4 2025-12-09 FORM 4 view ·
8-K 2025-12-04 8-K view ·
4 2025-11-17 FORM 4 view ·
4 2025-11-12 FORM 4 view ·
8-K 2025-11-10 8-K view ·
4 2025-10-31 FORM 4 view ·
10-Q 2025-10-29 10-Q view ·
8-K 2025-10-29 8-K view ·
8-K 2025-10-14 8-K view ·
8-K 2025-10-14 8-K view ·
4 2025-10-07 FORM 4 view ·
4 2025-10-03 FORM 4 view ·
8-K 2025-10-03 8-K view ·
4 2025-08-22 FORM 4 view ·
4 2025-08-21 FORM 4 view ·
4 2025-08-15 FORM 4 view ·
8-K 2025-08-13 8-K view ·
4 2025-08-12 FORM 4 view ·
4 2025-08-06 FORM 4 view ·
4 2025-08-04 FORM 4 view ·
10-Q 2025-08-01 10-Q view ·

About AVTR

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreacto…

Options picks · AVTR

ITM + OTM ideas from the latest scan

Loading…

Congress trades · AVTR

STOCK Act disclosures

Loading…

SEC filings & insiders · AVTR

EDGAR · live

Loading…

Holders · AVTR

Institutions & insider activity

Loading…